IL6 and type 2 diabetes mellitus: Our main findings in the present study were that the novel risk markers and tests IL-6, activin A, pathological recovery loop and E/Em all were significantly associated with a combined endpoint of CV events and mortality in a cohort of patients with type 2 diabetes at moderate CV risk.